OXiGENE is a biopharmaceutical company whose mission is finding and developing new and improved therapeutics that can deliver significant medical benefits to patients with cancer and sight-threatening eye diseases and conditions.

Thursday, February 25, 2010
OXiGENE Reports Fourth Quarter and Year-End 2009 Results

Friday, February 19, 2010
OXiGENE Announces Fourth Quarter and Fiscal 2009 Earnings Conference Call and Webcast